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Abstract
Protein supplementation during resistance exercise training augments hypertrophic gains. Protein ingestion and the
resultant hyperaminoacidemia provides the building blocks (indispensable amino acids – IAA) for, and also triggers
an increase in, muscle protein synthesis (MPS), suppression of muscle protein breakdown (MPB), and net positive
protein balance (i.e., MPS > MPB). The key amino acid triggering the rise in MPS is leucine, which stimulates the
mechanistic target of rapamycin complex-1, a key signalling protein, and triggers a rise in MPS. As such, ingested
proteins with a high leucine content would be advantageous in triggering a rise in MPS. Thus, protein quality
(reflected in IAA content and protein digestibility) has an impact on changes in MPS and could ultimately affect
skeletal muscle mass. Protein quality has been measured by the protein digestibility-corrected amino acid score
(PDCAAS); however, the digestible indispensable amino acid score (DIAAS) has been recommended as a better
method for protein quality scoring. Under DIAAS there is the recognition that amino acids are individual nutrients
and that protein quality is contingent on IAA content and ileal (as opposed to fecal) digestibility. Differences in
protein quality may have important ramifications for exercise-induced changes in muscle mass gains made with
resistance exercise as well as muscle remodelling. Thus, the purpose of this review is a critical appraisal of studies
examining the effects of protein quality in supplementation on changes in muscle mass and strength as well as
body composition during resistance training.
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Background
Performing resistance exercise results in a fundamentally
anabolic stimulus for skeletal muscle. When performed
often enough resistance training can result in varying de-
grees of muscular hypertrophy [1]. The degree of hyper-
trophy seen with resistance exercise training is, however,
highly variable [2–7] and likely dependent on a number
of variables including a persons’ prior training status,
sex, and age; however, the purpose of this review is not
to interrogate these variables and the interested reader is
directed to the following reviews [8–10]. A number of
lines of evidence show that ingestion of supplemental
protein during a program of resistance training can aug-
ment the hypertrophic and strength responses [11]. Re-
search has been undertaken to try and define how
protein can augment resistance training-induced training
responses and relevant variables have been examined in-
cluding protein quantity (dose) and protein timing (rela-
tive to exercise). While beyond the scope of this review,
recent reviews looking at the issues of protein dose [8]
and protein timing [12] are also excellent adjuncts to the
topic covered here. The impact of protein quality, using
PDCAAS estimates, on skeletal muscle anabolic re-
sponses, at rest, have recently been comprehensively
reviewed [13]; however, there has been less attention
paid to the impact of protein quality as a variable and its
importance in driving resistance training-induced hyper-
trophy. This is despite several instances showing that
protein quality can affect the acute post-exercise muscle
protein synthetic response [14] and muscle hypertrophy
with resistance training [5, 15, 16]. The focus of this re-
view is solely on muscular hypertrophy as a result of re-
sistance training and protein supplementation and not
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on strength. Recognizing that strength gains as a result
of resistance training, which while dependent on gains
in muscle mass/cross-sectional area, are likely equally as
dependent (or possibly even more so) on gains in neuro-
muscular factors. The aim of this review is to examine
how lower versus higher quality proteins impact the ad-
aptations to resistance exercise training with a focus on
skeletal muscle hypertrophy.
The role of supplemental protein in promoting muscle
hypertrophy
Muscle hypertrophy following resistance training is the
result of several processes [17] that include changes in
satellite cell content and activity (for review see [18]), as
well as protein turnover (for review see [8]). It is clear
from a number of studies that resistance exercise ‘sensi-
tizes’ the muscle to hyperaminoacidemia [19]. Thus, re-
sistance exercise has the effect of acting in a synergistic
manner with the normal rise in muscle protein synthesis
(MPS) that occurs with protein feeding (see the follow-
ing reviews [8, 20, 21] for more detail). Ultimately, resist-
ance exercise results in periods of extended positive
muscle protein balance, greater than those with feeding
alone. The effect of these extended periods of positive
protein balance is that the muscle fiber undergoes
addition of contractile protein mass and increases the
fiber size [8]. Supplementation (i.e., consumption of pro-
tein over and above a habitual protein intake) of a per-
sons’ normal dietary intake with various protein sources
has been shown to augment the hypertrophic response
with resistance training in both younger and older par-
ticipants [11, 22]. A meta-analysis shows that protein
timing (i.e., rapid consumption within a certain time
period pre-, during, or post-exercise) is not as important
in determining strength or hypertrophic gains [12].
Nonetheless, a pragmatic recommendation for athletes
and resistance trainees would still be to begin recovery
from exercise as soon as possible. Thus, post-exercise
protein consumption (as well as hydration and carbohy-
drate provision) has been shown to be effective at stimu-
lating MPS (reviewed here and elsewhere [8, 21]) and
thus is recommended over pre-exercise [23–25] or
during-exercise provision of protein [26], which would
have a more variable effect on MPS and possibly resist-
ance training-induced hypertrophy.
It has been shown that only the indispensable amino
acids (IAA) are required for the stimulation of MPS
[27–29] (here the term indispensable amino acid, as op-
posed to essential amino acid is used in keeping with
recommended usage [30, 31]). Of the IAA a position of
prominence belongs to leucine as an amino acid that
acts as a signaling molecule to stimulate MPS, as well as
being a building block for protein [32–35]. The medi-
ation of MPS by leucine is through the mechanistic
target of rapamycin complex-1 (mTORC1; for reviews
see [36–38]). It has recently been shown that a protein
named Sestrin2 is the leucine-binding sensor for
mTORC1 [39, 40]. Upon leucine binding with Sestrin2
there is dissociation of Sestrin2 and GATOR2 (a
GTPase-activating protein) and activation of mTORC1
to allow it to phosphorylate/de-phosphorylate down-
stream proteins and activate MPS. Thus, when leucine
binds to Sestrin2 this would stimulate MPS. The result,
as hypothesized [41–43], is that leucinemia (and subse-
quently intracellular leucine concentration) following
protein ingestion is a more likely determinant of muscle
protein accretion than total protein alone. With these
new understandings of how leucine is a stimulator of
MPS, it is noteworthy that commonly consumed sources
of supplemental proteins vary greatly in their leucine
content. A brief discussion of protein quality is import-
ant at this stage to understand the potential for how not
only protein quantity, but protein quality can impact
changes in MPS and potentially muscle mass with resist-
ance training.
Protein quality: PDCAAS and DIAAS
Typically, protein quality has been measured using the
protein digestibility-corrected amino acid score or
PDCAAS [44–46]. More recently, a new, ostensibly su-
perior, method for estimating protein quality has been
proposed called the digestible indispensable amino acid
score or DIAAS [31]. The main reasons for the deriv-
ation of the newer method of scoring protein quality re-
lated to concerns around the use of PDCAAS and an
increasing recognition that digestibility could not be es-
timated from feces. Some of the bases for why DIAAS is
suggested to be superior to PDCAAS are reviewed
briefly here. First, dietary amino acids should be treated
as individual nutrients and not simply as protein. Sec-
ond, it was acknowledged that any digestibility correc-
tion had to recognize the difference between fecal, as
opposed to ileal, protein digestibility. This is because
there is a rapid, and often times substantial metabolism
in terms of proteins, amino acids, and nitrogen in the
colon. Thus, ileal (i.e., end intestinal) rather than fecal
(which would include substantial microbiotic metabol-
ism) digestibility is considered to be more accurate due
to colonic protein and nitrogen metabolism [31]. Third,
there was a growing recognition that certain amino
acids, lysine as an example, can be reduced in terms of
their bioavailability due to chemical reactions that can
decrease the digestible lysine [31, 47]. Finally, there was
concern raised over truncation of the PDCAAS value,
which implied that amino acids available in terms of
their content over and above those contained in a refer-
ence protein, where not useful. The point was made that
truncation removes any nutritional differences between
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higher IAA-containing foods even if certain IAA may be
limiting in some diets/proteins. Thus, the solution is to
allow proteins, and the diets they are part of, to have an
amino acid score of ≥ 1.0. Table 1. Shows the PDCAAS
scores of some proteins and their corresponding DIAAS
score as well as the limiting amino acid. The equation
used to calculate the DIAAS, more details for which can
be found here [31], is given below:
DIAAS = (mg of digestible dietary IAA in dietary test
protein)/(mg of the same IAA in the reference protein)
Importantly, the reference protein in this equation is not
egg (as it was for PDCAAS) but a theoretical protein
that covers all of the known requirements for the IAA.
However, as with protein and the RDA, the requirement
levels of IAA that form the DIAAS score reflect the
minimum levels of intake of each amino acid. Thus,
there is no attempt to define ‘optimal’ and potentially
unique roles of amino acids such as leucine, as a stimu-
lator of MPS, as well as its role as a substrate for the
same process.
Beyond merely acting as a substrate, leucine has been
shown in a number of studies to be the AA that turns
on MPS [32–35]. This idea has been termed the leucine
‘threshold’ [8, 9, 41, 48], which is essentially a thesis that
states that a rapid (i.e., from easily digestible proteins)
post-prandial leucinemia, and likely the subsequent
intracellular leucine concentration (presumably through
leucine binding to Sestrin2 [39]), that triggers a rise in
MPS (Fig. 1). Thus, in situations where MPS is the vari-
able to be maximized it would be more important to
focus on the available leucine content (if known), rather
than a total IAA content. Thus, the leucine threshold is
an important concept since leucine is the amino acid
that turns on MPS [41, 48, 49] and, importantly, is most
likely the critical amino acid that is an important driver
of muscle hypertrophy. This thesis forms the basis of exam-
ination of studies in which proteins have been compared
with respect to not only their ability to stimulate MPS,
which is arguably a short-term measure not in complete
agreement with longer-term resistance training outcomes
[6, 50], but to promote resistance exercise-induced gains in
muscle mass. Protein amino acid content, which when
referenced to the ideal protein used in calculating DIAAS,
yields the amino acid reference ratio (AARR). The AARR
for leucine is shown for seven commonly consumed sup-
plemental proteins (Fig. 2). What is important to recognize
is that leucine is not, however, considered the limiting
amino acid (i.e., the amino acid present in lowest abun-
dance), which are shown in Table 1 for the same proteins.
In relation to the leucine trigger thesis (Fig. 1), it ap-
pears that the elderly have a greater leucine threshold
and thus require greater levels of protein/leucine to
stimulate MPS both at rest [42, 51] and following resist-
ance exercise [52, 53]. Thus, in an effort to produce
greater gains in muscle mass in the elderly, both with
Table 1 PDCAAS and DIAAS scores, the limiting amino acid
assessed by the amino acid reference ratio for selected proteins.
Values from [47]
Protein source PDCAAS DIAAS Limiting AA
Whey PI 1.00 1.09 His
Whey PC 1.00 0.97 His
Soy PI A 1.00 0.91 Met + Cys
Soy PI B 0.98 0.90 Met + Cys
Pea P 0.89 0.82 Met + Cys
Rice PC 0.42 0.37 Lys
PDCAAS protein digestibility-corrected amino acid score, DIAAS digestible
indispensable amino acid score, AA amino acid, PC protein concentrate, PI
protein isolate. Values are from reference [47]. Whey protein isolate (Whey PI)
8855, and whey protein concentrate (Whey PC) 392: all from the Fonterra
Co-operative Group; soy PI A (Supro 670) and soy PI B (Supro XF) were from
Solae; pea PC (Nutralys S85) from Roquette; and rice PC (Oryzatein 90) was
from Axiom Foods. Limiting AA – first limiting amino acid when compared to
an ideal protein
Fig. 1 Schematic showing the impact of proteins with differing
leucine contents on skeletal muscle fibre intracellular concentration
of leucine and subsequent stimulation of muscle protein synthesis
(MPS). The concept is that certain proteins with high leucine content
and digestibility would raise intracellular Leu concentration and bind
with Sestrin2 (see text for details) to trigger activation of MPS of
varying degrees (a). The resultant MPS response (shown as a percent
stimulation above resting) is shown in (b)
Phillips Nutrition & Metabolism  (2016) 13:64 Page 3 of 9
protein supplementation in the absence of exercise [54],
and with performance of resistance training larger doses
of protein (leucine) [11] would have to be consumed. The
higher protein/leucine needed to stimulate MPS in the
elderly would be obtained at lower protein doses with
higher quality proteins such as whey (Fig. 2, Table 1),
which may be advantageous from both an energy intake
and potential appetite suppression standpoint.
Whey protein supplementation and hypertrophy with
resistance training
A recent systematic review and meta-analysis of studies
involving the high leucine-containing protein whey has
been performed [16]. In this review the authors found
that of 14 studies included in the analysis 5 were whey
protein replacement studies (i.e., the whey protein was
not supplemental) and 9 were supplementation studies
[16]. The authors found, “…a statistically significant in-
crease in LBM [lean body mass] (WGMD [weighted
group mean difference]: 2.24 kg, 95 % CI, 0.66, 3.81)
among studies that included a resistance exercise com-
ponent along with WP provision.” The same authors
[16] concluded, “…[the findings] support the use of WP
[whey protein], either as a supplement combined with
resistance exercise or as part of a weight loss or weight
maintenance diet, to improve body composition parame-
ters.” It needs to be emphasized that in this same review
[16] the authors pointed out that, “…the effects of WP
[whey protein] were more favorable when compared
with carbohydrates than protein sources other than
whey, although findings did not reach statistical signifi-
cance.” This is to be expected since carbohydrates
provide only energy, not amino acids, and results only in
hyperinsulinemia and thus cannot stimulate a net positive
protein balance [55, 56]. Nonetheless, when considered
together the studies in which whey was compared to other
proteins [57–62] did not show marked differences. When
compared to soy, a lower quality protein (Table 1), whey
protein did not show a greater effect [57, 58]. However, in
only one study was resistance exercise included [57], but
this study had a very small sample size. Thus, the data are
limited and a firm conclusion is hard to form regarding an
advantage to supplementation with whey protein over
other protein sources. Since the publication of this meta-
analysis [16] there have been studies published in which
whey protein has been compared to soy protein [15], pea
protein [63], and rice protein [64].
Volek et al. [15] conducted a long-term training study
(9mo) in which a whey protein supplement was shown
to significantly enhance gains in lean body mass over
those seen in a soy protein-supplemented group by
~83 %. This study [15] is one of the longest protein sup-
plementation with resistance exercise trial and
highlighted the importance of protein quality in deter-
mining exercise-induced muscle mass gains. Given the
importance of leucine in triggering MPS, the findings of
a greater muscle mass gain in a whey supplemented
group are consistent with the leucine trigger thesis
(Fig. 1) for stimulation of MPS to promote hypertrophy.
Importantly, the soy supplemented group had a muscle
mass gain that was no different from the carbohydrate
group, which is a finding that implies soy was no better
than energy in the form of carbohydrate. While not
whey protein per se, the findings of Hartman et al. [5]
are aligned with those of Volek et al. [15]. In this study
[5] bovine skimmed milk was compared to a soy
protein-containing beverage and it was found that the
milk drinkers gained more muscle mass than did the soy
beverage consumers and a control carbohydrate only
consuming group.
Joy et al. [64] studied the influence of only 8weeks of
resistance training in groups of young men consuming
either 48 g/d of whey or the same quantity of rice-
derived protein (Oryzatein™ rice protein, Axiom Foods;
see Table 1). When compared on a weight and a digest-
ibility basis whey protein isolate has a much greater leu-
cine content and availability (Table 1), but the
researchers overcame this difference by feeding their
subjects a very large quantity of protein [64]. In feeding
their subjects 48 g of whey isolate and 48 g of rice pro-
tein concentrate they delivered doses of ~5.5 g and
~3.8 g of leucine, which would have hit the highest level
of leucine (Fig. 1) and saturated the MPS response for
both group [65]. Thus, given the saturable dose-
response nature of MPS [52, 65, 66], and the subsequent
hypertrophy, the results from this study [64] are not
Fig. 2 The Leucine (Leu) amino acid reference ratio (AARR – defined
as the content of leucine in the protein measured compared to a
hypothetical best protein to provide the EAA needed) for various
protein concentrates and protein isolates. Values are from reference
[47]. Whey PI and PC 392: all from the Fonterra Co-operative Group;
soy PI A (Supro 670) and soy PI B (Supro XF) were from Solae; pea
PC (Nutralys S85) from Roquette; and rice PC (Oryzatein 90) was from
Axiom Foods. Values are from reference [47]
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surprising. By halving the doses that these authors used
[64], which arguably represents a more realistic dose of
protein, then the whey protein dose would still be suffi-
cient to maximally stimulate MPS whereas the rice pro-
tein dose would not [52, 65, 66]. Thus ‘equivalency’ of
protein in this study was not a function of the protein
quality itself, but of the large per-dose quantities of pro-
tein (leucine) consumed. Clearly these doses of protein
were sufficient to maximally stimulate MPS in the case
of both the rice and the whey supplement.
Babault and colleagues [63] conducted a study in
young men consuming either a placebo, pea protein, or
whey protein. This study was a large-scale trial in which
137 subjects were included for analysis (n = 47, 46, and
44, respectively for the placebo, pea protein, and whey
protein concentrate supplemented group). It could not
be determined in this study whether the protein was
truly supplemental due to a lack of reporting dietary in-
take data. The extra protein provided would have deliv-
ered, on a per dose basis, 1.6 g of leucine in the pea
protein and 2.1 g of leucine in the whey group (both
consumed twice daily) [63]. From all we know at present
[41, 48, 49, 65], both of these doses were likely below an
optimal leucine dose to stimulate MPS. Subjects did not
engage in a full resistance exercise training program but
instead performed only three resistance exercises: arm
curl, lateral pulldown, and bench press, which they en-
gaged in three times weekly for 12 weeks [63]. The re-
sults measured as biceps brachii muscle thickness
showed all groups increased the thickness of their
muscle (muscle thickness served here as a proxy for
muscle hypertrophy), and the extent of the increase in
muscle thickness was labelled by the authors as ‘trend-
ing’ to be different in the pea protein versus the whey
protein supplemented group [63]. Fig. 3a shows the
changes in mean muscle thickness from week 0 to week
12 in all groups. Interestingly, the increase in muscle
thickness was accompanied by similar increases in
strength in all groups. Thus, if as the authors suggested
pea protein induced a ‘greater’ increase in muscle thick-
ness/hypertrophy then the quality of the muscle (as force
per cross-sectional area) gained would not be as great in
the pea protein supplemented group than the placebo or
whey protein supplemented groups. It is also hard, based
on reported data from this study [63], to ascertain the
significance of what the changes in muscle thickness
meant in terms of true hypertrophy. Highlighting this
fact, the arm circumferences reported by these authors
are shown in Fig. 3b and the estimated change, based on
means, are shown in Fig. 3c. While admitting the arm
circumference is a crude measure of muscle hypertrophy
it does, when comparing Fig. 3a, b, and c call into ques-
tion what a difference in muscle thickness of less than
1 mm between the whey and pea protein supplemented
groups actually means in terms of hypertrophy. In future
studies, rather than proxy measures (i.e., muscle thick-
ness), an actual measurement of hypertrophy using MRI,
muscle fibre CSA, or the use of CT would be beneficial.
The authors of this study [63] also conducted a ‘sensitiv-
ity’ analysis by analyzing only the changes in muscle
Fig. 3 Reanalysis of data from Babault et al. [63], showing changes
in muscle thickness in all groups (a) with data estimated from mean
changes. Arm circumferences (b) from the same study. And the
changes, estimated from means, of the change in arm circumference
of the three groups (c)
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thickness for those participants who had initial arm curl
maximal strength less than the median of 25 kg. One
issue with this ‘sensitivity’ analysis is that by partitioning
subjects by strength lead to groups that had n = 17 for
pea (36 % of the total sample for that group), n = 31 for
whey (67 % of the total sample for that group), and n =
20 for placebo (45 % of the total sample for that group)
participants for the pea, whey, and placebo groups, re-
spectively. This analysis highlights the fact that weaker
subjects were disproportionately assigned to the whey
group and that a ‘sensitivity’ analysis along strength cre-
ated imbalanced group sizes and a situation for a type 2
statistical error. The authors stated that, “Thickness in-
creases between D0 and D84 were +20.2 ± 12.3 %, +15.6
± 13.5 %, and +8.6 ± 7.3 % for Pea, Whey and Placebo,
respectively. A Scheffé test showed a statistically signifi-
cant difference between Pea and Placebo [2.51 mm]
whereas there was no significant difference between
Whey and Pea [1.21 mm]… nor between Whey and Pla-
cebo [1.29 mm].” (p. 5) [63]. A number of the findings
and claims that the results of this study [63] were due to
pea protein are difficult to reconcile with the leucine con-
tent and availability of the pea versus the whey protein
(Table 1 and Fig. 2) and known relationships with leucine
and MPS [52, 65, 66]. Moreover, the ‘sensitivity’ analysis
used by these authors created an imbalanced group as-
signment that lead to the creation of disproportionate
group sizes and, it is proposed, a spurious conclusion
regarding the efficacy of pea versus whey protein.
Protein blends
Blended proteins (mixtures of different isolated protein
sources) have been sparingly studied, but in all cases where
MPS has been measured blends of proteins give similar re-
sponses to leucine-matched whey protein [67, 68]. A theory
behind why blends of proteins might be considered to be
more effective than isolated proteins would be that the de-
livery of amino acids could be extended or that certain
amino acids are enriched in some sources [69]; however, as
the main driver of MPS the most relevant amino acid is
leucine. For example, Reidy et al. compared a blend of whey
(25 % by weight), caseinate (50 % by weight), and soy (25 %
by weight) to a leucine-matched quantity of whey. There
were differences in the aminoacidemia obtained following
ingestion of these two treatments that were accompanied
by different time courses of muscle protein synthesis, how-
ever, on balance the incorporation of amino acids into
muscle protein was not different between treatments. These
findings are in agreement with the leucine trigger concept
(Fig. 1) and highlight the importance of leucine as an amino
acid that needs to be considered in comparing supplemen-
tal sources of protein. Future research on blends of protein
will need to focus on comparing protein blends to other
protein sources in longer-term studies with hypertrophy
and/or strength as a main outcome.
Other supplemental proteins
A number of other supplemental protein sources have now
become available to consumers including hemp protein
and ‘insect-based’ protein, and other plant-derived proteins.
While it is not possible to make specific comparisons to the
proteins examined here, the leucine content and quality
(due to processing and the presence of anti-nutritional
compounds [70] unless they are removed) will be lower
than most if not all more commonly available supplemental
proteins (Table 1). For example, the PDCAAS (DIAAS is
not available) scores were estimated by House et al. [71] to
be 0.49–0.53 for whole hemp seed, 0.46–0.51 for hemp
seed meal, 0.63–0.66 for dehulled hemp seed. Obviously,
the hull of the seed contained a high quantity of antinutri-
tional factors and its removal improved protein quality. Ly-
sine was the first limiting amino acid in all hemp-based
proteins [71]. It is important that these proteins now be
assessed and their DIAAS scores estimated so that we can
make a true assessment of their quality when compared to
more commonly-used isolated proteins.
Collagen has also gained in popularity as a source of
protein in supplemental sources. This is intriguing given
the PDCAAS score of collagen is zero due to the fact that
it is lacking in tryptophan. However, protein blends con-
taining collagen, which even with added tryptophan would
have a PDCAAS score of 0.39, would add mostly dispens-
able amino acids (and admittedly protein content on the
product label) to existing protein content and would not
improve protein quality. In addition to collagen a variety
of insect-derived proteins have been assessed for their
protein quality and, not unsurprisingly, there are wide
variation in protein digestibility [72]. Nonetheless, insect
protein tends, in general, to be lower quality and lower in
IAA than comparable proteins we have examined here.
Most often, in protein sources claiming to be insect pro-
tein, that are available for human consumption, they are
not pure insect protein but instead blends of insect and
other proteins such as a rice, hemp, and/or soy protein.
Thus, the protein quality of such protein blends is a func-
tion not of the insects and unlikely to be as high as most
common supplemental proteins (Table 1). As a result, to
achieve a dose of leucine sufficient to stimulate MPS to an
appreciable degree unless larger quantities (40–50 g per
serve) of the protein are consumed; thus, these protein
sources would be inferior to those proteins described in
Table 1. It is important that future studies in this area
emphasize that discussion of protein ‘quality’ using at least
the content of IAA, PDCAAS (if available), or DIAAS (if
possible) to accurately characterize proteins for use in hu-
man clinical research.
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Recommendation and future directions
Future studies in which protein is given to participants
to assess the impact of this macronutrient on resistance
training-induced hypertrophy need to consider the
following:
1. Is the protein given a supplement? A supplemental
protein, by definition, is in addition to the persons’
normal dietary intake. Thus, researchers are urged
to make some effort to assess normal dietary intake
prior to the supplementation and exercise
intervention.
2. Is the allocation of the protein supplements blinded
and is subject compliance assessed? While blinding of
the subjects and investigators to the supplementation
is self-explanatory, objective measures of compliance
are rarely used. As one biomarker of compliance with
an increased protein intake urinary or serum urea
levels could be assessed.
3. Is the study of sufficient duration and is adequately
powered to detect differences? While the time
course of muscle hypertrophy is not known exactly
an 8weeks intervention would be considered the
minimum as true hypertrophy (i.e., measured with
muscle biopsies or by MRI and/or CT) is detectable/
measurable after 6–8 weeks of resistance training
[73–76]. Study power is often not mentioned, but it
should be and the minimum significant effect as well
as the degree of change in hypertrophy needs to be
outlined. To detect hypertrophy differences in
proteins of differing protein quality it appears that
this should be in the range of at least 25 subjects per
group [5, 15] and for a period of at least 10–12
weeks in novice lifters and possibly longer in
experienced lifters.
4. CONSORT (http://www.consort-statement.org/)
guidelines need to be followed. The CONSORT
guidelines provide a minimum set of
recommendations for reporting of randomized trials.
Adherence to this standard allows an easy cross-
comparison of one trial to the next. This aids in
standardization, complete and transparent reporting,
and aids in interpretation.
5. An appropriate placebo needs to be used.
Comparisons of protein to carbohydrate (i.e., to
try and make the interventions isoenergetic, but
not isonitrogenous) are more likely to show an
effect of supplementation. Some studies have
compared protein sources based on leucine
content [67], with the expected outcome that
protein turnover is no different between the two,
however, it would seem to make more sense to
compare protein sources and doses that are
isonitrogenous.
A further consideration in recommendations for using
lower quality proteins is their potential use in populations
such as the elderly for whom a requirement for protein
[77, 78], and more importantly leucine [42, 79, 80], for re-
tention of muscle mass appears to be higher than that of
younger persons. For older persons lower quality protein
sources would have to be rigorously tested. This sentiment
would be particularly true in older persons with marginal
energy intake and or lower levels of physical activity for
whom high quality (and nutrient-dense) sources of protein
would be recommended [54, 81, 82].
Conclusions
Protein quality appears to play a role in determining re-
sistance exercise-induced muscle hypertrophy; however,
the effect is more difficult to detect compared to a com-
parison between the protein and an isoenergetic source
of carbohydrate. The leucine content of a protein is the
strongest determinant of the capacity of a protein to
affect MPS and likely hypertrophy. While the prior per-
formance of exercise will lower the threshold for pro-
tein/leucine required to stimulate MPS the importance
of leucine content for MPS and likely subsequent hyper-
trophy needs to be appreciated in the context of not
only its content in a protein source but also its digest-
ibility. While there are few studies that have actually de-
rived the DIAAS of proteins this variable is something
that needs to be considered moving forward. When
comparing proteins of differing quality, larger adequately
powered rigorous trials need to be run to assess the im-
pact of protein quality in determining resistance
exercise-induced hypertrophy. Future studies in this area
may wish to consider the recommendations outlined
here in terms of trying to improve overall study quality
and, importantly, to allow for easier comparisons be-
tween trials.
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